UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 36 filers reported holding UROVANT SCIENCES LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $8,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 157,480 | $2,443,000 | 1.17% |
| Wildcat Capital Management, LLC | 219,975 | $3,412,000 | 0.98% |
| Perceptive Advisors | 2,406,931 | $37,331,000 | 0.74% |
| Sio Capital Management, LLC | 160,442 | $2,488,000 | 0.59% |
| Park West Asset Management LLC | 432,500 | $6,708,000 | 0.28% |
| LVW Advisors, LLC | 39,312 | $610,000 | 0.14% |
| Baker Brothers Advisors | 1,000,000 | $15,510,000 | 0.08% |
| EcoR1 Capital, LLC | 26,468 | $411,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 950,000 | $14,735,000 | 0.04% |
| Alyeska Investment Group, L.P. | 177,731 | $2,757,000 | 0.04% |